paclitaxel,olaparib,cisplatin,bevacizumab,pembrolizumab,carboplatin,durvalumab,gemcitabine,pemetrexed,atezolizumab,talazoparib
roche,merck,astrazeneca,pfizer
['keynote-671', 'keynote,671', 'keynote-826', 'duo-o']
the round up
day2 of #asco23 covering:
keynote-671 swog s1929 keynote-826 duo-o best, 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨